Skip to main content
Fig. 2 | Trials

Fig. 2

From: Study design of the DAS-OLT trial: a randomized controlled trial to evaluate the impact of dexmedetomidine on early allograft dysfunction following liver transplantation

Fig. 2

Study schedule showing time points for enrollment and assessment. The informed consent and examination will be conducted after recruitment. Then, participants will be randomized into two groups. Adverse events will be recorded in the case report form at any time during the study. Postoperative graft evaluation includes EAD, PNF, AKI, and ARDS

Back to article page

Trials

ISSN: 1745-6215